SALL4 is expressed in 75% of chronic myeloid leukemia (CML) patients in blast-crisis, but expressed in just 10% of patients in the chronic phase. This evidence concerns the gene SALL4 and chronic myelogenous leukemia, BCR-ABL1 positive.